| __timestamp | Amneal Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 205018000 |
| Thursday, January 1, 2015 | 367054000 | 392709000 |
| Friday, January 1, 2016 | 420770000 | 299694000 |
| Sunday, January 1, 2017 | 507476000 | 397061000 |
| Monday, January 1, 2018 | 946588000 | 434100000 |
| Tuesday, January 1, 2019 | 1273376000 | 782200000 |
| Wednesday, January 1, 2020 | 1364130000 | 1119900000 |
| Friday, January 1, 2021 | 1324696000 | 2437500000 |
| Saturday, January 1, 2022 | 1427596000 | 1560400000 |
| Sunday, January 1, 2023 | 1573042000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Data in motion
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. This analysis delves into the cost of revenue trends for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Regeneron has demonstrated a remarkable increase in cost efficiency, with its cost of revenue peaking at approximately 1.82 billion in 2023, a significant rise from 205 million in 2014. This represents an impressive growth of nearly 785% over the decade.
Conversely, Amneal Pharmaceuticals has also seen a steady increase, with its cost of revenue growing from 336 million in 2014 to 1.57 billion in 2023, marking a 368% increase. This data highlights the dynamic nature of the pharmaceutical industry, where strategic cost management can lead to substantial financial growth. As these companies continue to innovate, their cost efficiency will remain a critical factor in their success.
Comparing Cost of Revenue Efficiency: AbbVie Inc. vs Amneal Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Cytokinetics, Incorporated vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Amneal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated